Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07032571 · ClinicalTrials.gov registry record · NA
Reset: Enhancing Weight Loss in a Digital Intervention
A NA study, sponsored by Stanford University.
- Not yet
- Registry status
- NA
- Development phase
- 208
- Enrollment target
NCT07032571: Clinical Trial NA study, sponsored by Stanford University.
NCT07032571 is a NA study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 208 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07032571, a NA study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 208 participants
- Enrollment target
Study Summary
The goal of the Reset trial is to learn about the optimal combination of dietary behavior strategies in a fully digital weight loss intervention. The intervention is designed for adults with overweight or obesity. The investigators will examine the impact on weight loss of four dietary strategies: 1) limiting Red Zone Foods (i.e., foods that are high in calories and low in nutrition), 2) limiting eating windows, 3) increasing protein intake, and 4) increasing fiber intake. Each of these strategies will include goal setting, daily self-monitoring, and tailored feedback. The investigators will recruit 208 participants. Broadly, adults with overweight or obesity who live in the U.S. will be eligible. The weight loss intervention will last 12 weeks. All participants will be asked to track their body weight daily and complete weekly behavioral lessons and action plans to promote healthy eating and physical activity. All study tasks will occur remotely. Assessment of body weight and survey measures will occur at the beginning of the trial ("baseline"), and at 1 month and 3 months. The Multiphase Optimization Strategy (MOST) framework will be used to identify which combination of the dietary behavior strategies results in the greatest weight loss. In total, there will be 16 treatment conditions.
Primary Outcome
mean change in kg; assessed via participants' personal scales
Interventions
- BEHAVIORAL Core Behavioral Weight Loss Intervention
- BEHAVIORAL Limit Red Zone Foods
- BEHAVIORAL Limit Eating Window
- BEHAVIORAL Increase Protein
- BEHAVIORAL Increase Fiber Intake
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2026-04 |
| Est. Completion | 2026-08 |
| Phase | NA |
What is known before NCT07032571 opens enrollment
NCT07032571 is an interventional study that assigns participants to a tested intervention. The registered 208 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 5 interventions - of which Core Behavioral Weight Loss Intervention is the first listed.
NCT07032571 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07032571 about?
NCT07032571 is a clinical study titled "Reset: Enhancing Weight Loss in a Digital Intervention". The goal of the Reset trial is to learn about the optimal combination of dietary behavior strategies in a fully digital weight loss intervention. The intervention is designed for adults with overweight or obesity. The investigators will examine the impact on weight loss of four dietary strategies: 1...
What is the current status of trial NCT07032571?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 208 participants. The study started on 2026-04. Estimated completion is 2026-08.
What interventions are being tested in trial NCT07032571?
The interventions under investigation include: Core Behavioral Weight Loss Intervention (BEHAVIORAL), Limit Red Zone Foods (BEHAVIORAL), Limit Eating Window (BEHAVIORAL), Increase Protein (BEHAVIORAL), Increase Fiber Intake (BEHAVIORAL).
Who is sponsoring clinical trial NCT07032571?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07032571's enrollment target sits among peer trials
208 496th of 2000 higher than 1,502 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465774 · 208 participants
Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions
- NCT03803332 · 208 participants · NA
A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel
- NCT04732065 · 208 participants · Phase 1
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- NCT05293756 · 208 participants · NA
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia